APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Belladonna Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Belladonna Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173969630328 December 2025197 pages

Choose your research edition.

Industry ResearchBelladonna Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Belladonna Tablets Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Belladonna Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Belladonna Tablets Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Belladonna Tablets Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Belladonna Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Belladonna Tablets include Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd., Yangzhou Aidi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Wanbangde Pharmaceutical Group Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd., Shenyang Tonglian Pharmaceutical Co., Ltd., Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd., Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. and Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Belladonna Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Belladonna Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Belladonna Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Belladonna Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Belladonna Tablets Segment by Company

Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.

Yangzhou Aidi Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Wanbangde Pharmaceutical Group Co., Ltd.

CSPC Ouyi Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.

Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.

Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.

Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.

Jilin Luwang Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Jilin Daojun Pharmaceutical Co., Ltd.

Henan Baiquan Pharmaceutical Co., Ltd.

Sinopharm Xinjiang Pharmaceutical Co., Ltd.

Guangxi Dahaiguang Pharmaceutical Co., Ltd.

Gansu Lanyao Pharmaceutical Co., Ltd.

Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.

Aimin Pharmaceutical Group Co., Ltd.

Weleda

Raritan Pharmaceuticals

Hyland's Inc

Belladonna Tablets Segment by Type

Compound Preparations

Single Preparations

Belladonna Tablets Segment by Application

Hospital

Clinic

Other

Belladonna Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Belladonna Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Belladonna Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Belladonna Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Belladonna Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Belladonna Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Belladonna Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Belladonna Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Belladonna Tablets Industry Trends Table 2. Belladonna Tablets Industry Drivers Table 3. Belladonna Tablets Industry Opportunities and Challenges Table 4. Belladonna Tablets Industry Restraints Table 5. Global Belladonna Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Belladonna Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Belladonna Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Belladonna Tablets Sales Market Share by Manufacturers Table 9. Global Belladonna Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Belladonna Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Belladonna Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Belladonna Tablets Manufacturers, Product Type & Application Table 13. Global Belladonna Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Belladonna Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Compound Preparations Table 17. Major Manufacturers of Single Preparations Table 18. Global Belladonna Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Belladonna Tablets Sales Market Share by Type (2021-2026) Table 22. Global Belladonna Tablets Sales Market Share by Type (2027-2032) Table 23. Global Belladonna Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Belladonna Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Belladonna Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Belladonna Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Belladonna Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Belladonna Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Belladonna Tablets Sales Market Share by Application (2021-2026) Table 35. Global Belladonna Tablets Sales Market Share by Application (2027-2032) Table 36. Global Belladonna Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Belladonna Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Belladonna Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Belladonna Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Belladonna Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Belladonna Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Belladonna Tablets Sales Market Share by Region (2021-2026) Table 44. Global Belladonna Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Belladonna Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Belladonna Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Belladonna Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Belladonna Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Belladonna Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Belladonna Tablets Revenue Market Share by Region (2027-2032) Table 63. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information Table 64. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview Table 65. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio Table 67. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Development Table 68. Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information Table 69. Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview Table 70. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 72. Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Development Table 73. Southwest Pharmaceutical Co., Ltd. Company Information Table 74. Southwest Pharmaceutical Co., Ltd. Business Overview Table 75. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 77. Southwest Pharmaceutical Co., Ltd. Recent Development Table 78. Wanbangde Pharmaceutical Group Co., Ltd. Company Information Table 79. Wanbangde Pharmaceutical Group Co., Ltd. Business Overview Table 80. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 82. Wanbangde Pharmaceutical Group Co., Ltd. Recent Development Table 83. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information Table 84. CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview Table 85. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 87. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development Table 88. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 89. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 90. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 92. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 93. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information Table 94. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview Table 95. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 97. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Development Table 98. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information Table 99. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview Table 100. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 102. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Development Table 103. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information Table 104. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview Table 105. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 107. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Development Table 108. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information Table 109. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview Table 110. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio Table 112. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Development Table 113. Jilin Luwang Pharmaceutical Co., Ltd. Company Information Table 114. Jilin Luwang Pharmaceutical Co., Ltd. Business Overview Table 115. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 117. Jilin Luwang Pharmaceutical Co., Ltd. Recent Development Table 118. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 119. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 120. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 122. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 123. Jilin Daojun Pharmaceutical Co., Ltd. Company Information Table 124. Jilin Daojun Pharmaceutical Co., Ltd. Business Overview Table 125. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 127. Jilin Daojun Pharmaceutical Co., Ltd. Recent Development Table 128. Henan Baiquan Pharmaceutical Co., Ltd. Company Information Table 129. Henan Baiquan Pharmaceutical Co., Ltd. Business Overview Table 130. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 132. Henan Baiquan Pharmaceutical Co., Ltd. Recent Development Table 133. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information Table 134. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview Table 135. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 137. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Development Table 138. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information Table 139. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview Table 140. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 142. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Development Table 143. Gansu Lanyao Pharmaceutical Co., Ltd. Company Information Table 144. Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview Table 145. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 147. Gansu Lanyao Pharmaceutical Co., Ltd. Recent Development Table 148. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information Table 149. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 150. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 152. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 153. Aimin Pharmaceutical Group Co., Ltd. Company Information Table 154. Aimin Pharmaceutical Group Co., Ltd. Business Overview Table 155. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 157. Aimin Pharmaceutical Group Co., Ltd. Recent Development Table 158. Weleda Company Information Table 159. Weleda Business Overview Table 160. Weleda Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Weleda Belladonna Tablets Product Portfolio Table 162. Weleda Recent Development Table 163. Raritan Pharmaceuticals Company Information Table 164. Raritan Pharmaceuticals Business Overview Table 165. Raritan Pharmaceuticals Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Raritan Pharmaceuticals Belladonna Tablets Product Portfolio Table 167. Raritan Pharmaceuticals Recent Development Table 168. Hyland's Inc Company Information Table 169. Hyland's Inc Business Overview Table 170. Hyland's Inc Belladonna Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Hyland's Inc Belladonna Tablets Product Portfolio Table 172. Hyland's Inc Recent Development Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Belladonna Tablets Distributors List Table 176. Belladonna Tablets Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Belladonna Tablets Product Image Figure 2. Global Belladonna Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Belladonna Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Belladonna Tablets Sales (2021-2032) & (K Units) Figure 5. Global Belladonna Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Belladonna Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Compound Preparations Image Figure 9. Single Preparations Image Figure 10. Global Belladonna Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Belladonna Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Belladonna Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Belladonna Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Belladonna Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Belladonna Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Belladonna Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Belladonna Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Belladonna Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Belladonna Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Belladonna Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Belladonna Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 39. China Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Belladonna Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Belladonna Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Belladonna Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Belladonna Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Belladonna Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Belladonna Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Belladonna Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Belladonna Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Belladonna Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Compound Preparations
  • Single Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  • Yangzhou Aidi Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Wanbangde Pharmaceutical Group Co., Ltd.
  • CSPC Ouyi Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  • Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  • Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  • Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  • Jilin Luwang Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • Jilin Daojun Pharmaceutical Co., Ltd.
  • Henan Baiquan Pharmaceutical Co., Ltd.
  • Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  • Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  • Gansu Lanyao Pharmaceutical Co., Ltd.
  • Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  • Aimin Pharmaceutical Group Co., Ltd.
  • Weleda
  • Raritan Pharmaceuticals
  • Hyland's Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Belladonna Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Belladonna Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Belladonna Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Belladonna Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Belladonna Tablets Market Dynamics
  1. 2.1 Belladonna Tablets Industry Trends
  2. 2.2 Belladonna Tablets Industry Drivers
  3. 2.3 Belladonna Tablets Industry Opportunities and Challenges
  4. 2.4 Belladonna Tablets Industry Restraints
3 Belladonna Tablets Market by Manufacturers
  1. 3.1 Global Belladonna Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Belladonna Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Belladonna Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Belladonna Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Belladonna Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Belladonna Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Belladonna Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Belladonna Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Belladonna Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Belladonna Tablets Tier 1, Tier 2, and Tier 3
4 Belladonna Tablets Market by Type
  1. 4.1 Belladonna Tablets Type Introduction
  2. 4.1.1 Compound Preparations
  3. 4.1.2 Single Preparations
  4. 4.2 Global Belladonna Tablets Sales by Type
  5. 4.2.1 Global Belladonna Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Belladonna Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Belladonna Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Belladonna Tablets Revenue by Type
  9. 4.3.1 Global Belladonna Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Belladonna Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Belladonna Tablets Revenue Market Share by Type (2021-2032)
5 Belladonna Tablets Market by Application
  1. 5.1 Belladonna Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Belladonna Tablets Sales by Application
  6. 5.2.1 Global Belladonna Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Belladonna Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Belladonna Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Belladonna Tablets Revenue by Application
  10. 5.3.1 Global Belladonna Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Belladonna Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Belladonna Tablets Revenue Market Share by Application (2021-2032)
6 Global Belladonna Tablets Sales by Region
  1. 6.1 Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Belladonna Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Belladonna Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Belladonna Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Belladonna Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Belladonna Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Belladonna Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Belladonna Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Belladonna Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Belladonna Tablets Revenue by Region
  1. 7.1 Global Belladonna Tablets Revenue by Region
  2. 7.1.1 Global Belladonna Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Belladonna Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Belladonna Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Belladonna Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Belladonna Tablets Revenue (2021-2032)
  8. 7.2.2 North America Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Belladonna Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Belladonna Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Belladonna Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Belladonna Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  2. 8.1.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information
  3. 8.1.2 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview
  4. 8.1.3 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio
  6. 8.1.5 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Developments
  7. 8.2 Yangzhou Aidi Pharmaceutical Co., Ltd.
  8. 8.2.1 Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  12. 8.2.5 Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Southwest Pharmaceutical Co., Ltd.
  14. 8.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  18. 8.3.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Wanbangde Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Wanbangde Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Wanbangde Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  24. 8.4.5 Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 CSPC Ouyi Pharmaceutical Co., Ltd.
  26. 8.5.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  30. 8.5.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shenyang Tonglian Pharmaceutical Co., Ltd.
  32. 8.6.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  36. 8.6.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  38. 8.7.1 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  42. 8.7.5 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  44. 8.8.1 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  48. 8.8.5 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  50. 8.9.1 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  54. 8.9.5 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  56. 8.10.1 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information
  57. 8.10.2 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview
  58. 8.10.3 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio
  60. 8.10.5 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 8.11 Jilin Luwang Pharmaceutical Co., Ltd.
  62. 8.11.1 Jilin Luwang Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  66. 8.11.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jilin Hengjin Pharmaceutical Co., Ltd.
  68. 8.12.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  72. 8.12.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Daojun Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Daojun Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Daojun Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  78. 8.13.5 Jilin Daojun Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Henan Baiquan Pharmaceutical Co., Ltd.
  80. 8.14.1 Henan Baiquan Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Henan Baiquan Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  84. 8.14.5 Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  86. 8.15.1 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  90. 8.15.5 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  96. 8.16.5 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Gansu Lanyao Pharmaceutical Co., Ltd.
  98. 8.17.1 Gansu Lanyao Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  102. 8.17.5 Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  104. 8.18.1 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  108. 8.18.5 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Aimin Pharmaceutical Group Co., Ltd.
  110. 8.19.1 Aimin Pharmaceutical Group Co., Ltd. Company Information
  111. 8.19.2 Aimin Pharmaceutical Group Co., Ltd. Business Overview
  112. 8.19.3 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  114. 8.19.5 Aimin Pharmaceutical Group Co., Ltd. Recent Developments
  115. 8.20 Weleda
  116. 8.20.1 Weleda Company Information
  117. 8.20.2 Weleda Business Overview
  118. 8.20.3 Weleda Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Weleda Belladonna Tablets Product Portfolio
  120. 8.20.5 Weleda Recent Developments
  121. 8.21 Raritan Pharmaceuticals
  122. 8.21.1 Raritan Pharmaceuticals Company Information
  123. 8.21.2 Raritan Pharmaceuticals Business Overview
  124. 8.21.3 Raritan Pharmaceuticals Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Raritan Pharmaceuticals Belladonna Tablets Product Portfolio
  126. 8.21.5 Raritan Pharmaceuticals Recent Developments
  127. 8.22 Hyland's Inc
  128. 8.22.1 Hyland's Inc Company Information
  129. 8.22.2 Hyland's Inc Business Overview
  130. 8.22.3 Hyland's Inc Belladonna Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Hyland's Inc Belladonna Tablets Product Portfolio
  132. 8.22.5 Hyland's Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Belladonna Tablets Value Chain Analysis
  2. 9.1.1 Belladonna Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Belladonna Tablets Production Mode & Process
  6. 9.2 Belladonna Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Belladonna Tablets Distributors
  9. 9.2.3 Belladonna Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst